Search Within

Daniel C Danila

  1. "Computational Oncology Service"
Formats
  1. Journal Article (8)
  2. Meeting Abstract (8)
Groups
  1. Computational Oncology Service (16)
  2. Department of Medicine (16)
  3. Epidemiology and Biostatistics (16)
  4. GSK Faculty (16)
  5. Genitourinary Oncology Service (16)
  6. Human Oncology and Pathogenesis Program (16)

More Groups

People
  1. Nikolaus Schultz (16)
  2. Howard Scher (15)
  3. Dana Rathkopf (9)
  4. David Solit (9)
  5. Michael Berger (8)
  6. Michael Morris (8)

More People

Years
  1. 2024 (1)
  2. 2022 (1)
  3. 2020 (1)
  4. 2019 (1)
  5. 2018 (1)
  6. 2017 (2)

More Years

Publications
  1. Journal of Clinical Oncology (7)
  2. JCO Precision Oncology (3)
  3. Clinical Cancer Research (2)
  4. Annals of Oncology (1)
  5. Cancer Research (1)
  6. European Urology (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (10)
  2. American Association for Cancer Research (3)
  3. American Medical Association (1)
  4. Elsevier Science, Inc. (1)
  5. Oxford University Press (1)

Results (16)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Prostate-specific mRNA detection in whole blood as an analytically validated prognostic biomarker for patients with castration-resistant prostate cancer (CRPC)
    Meeting Abstract

    Danila, D. C.; Anand, A.; Heller, G.; Wan, M.; Herkal, A.; Patel, C.; Khanin, R.; Schultz, N.; Lilja, H.; Fleisher, M.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Prostate-specific mRNA detection in whole blood as an analytically validated prognostic biomarker for patients with castration-resistant prostate cancer (CRPC)
    Meeting Abstract

    Anand, A.; Danila, D. C.; Heller, G.; Herkal, A.; Patel, C.; Khanin, R.; Schultz, N.; Lilja, H.; Fleisher, M.; Scher, H. I.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • The analytic validation of prostate-specific mRNA detection in whole blood by RT-PCR as a prognostic biomarker for patients with castration- resistant prostate cancer (CRPC)
    Meeting Abstract

    Danila, D. C.; Anand, A.; Heller, G.; Wan, M.; Zehnder, M.; Khanin, R.; Schultz, N.; Fleisher, M.; Lilja, H.; Scher, H. I.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Distinct patterns of dysregulated expression of enzymes involved in androgen synthesis and metabolism in metastatic prostate cancer tumors
    Journal Article

    Mitsiades, N.; Sung, C. C.; Schultz, N.; Danila, D. C.; He, B.; Eedunuri, V. K.; Fleisher, M.; Sander, C.; Sawyers, C. L.; Scher, H. I.
    Cancer Research (2012)

    Fulltext@MSK | Save
  • The analytical validation of prostate specific mRNA detection in whole blood by reverse transcription-polymerase chain reaction (RT-PCR) as a prognostic biomarker for patients with castration-resistant prostate cancer (CRPC)
    Meeting Abstract

    Danila, D.; Anand, A.; Heller, G.; Wan, M.; Zehnder, M.; Khanin, R.; Schultz, N.; Fleisher, M.; Lilja, H.; Scher, H. I.
    Annals of Oncology (2012)

    Fulltext@MSK | Save
  • A gene expression signature associated with sensitivity to the multikinase inhibitor dasatinib: Implications for development of a noninvasive biomarker for personalized therapy based on circulating tumor cell analysis
    Meeting Abstract

    Mitsiades, N.; Antipin, Y.; Reva, B.; Schultz, N.; Danila, D. C.; Sung, C. C.; Anand, A.; Sander, C.; Scher, H. I.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save